Innoviva logo

Innoviva Share Price Today

(NASDAQ: INVA)

Innoviva share price is $18.32 & ₹1,595.58 as on 5 Feb 2025, 2.30 'hrs' IST

$18.32

-0.09

(-0.49%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Innoviva share price in Dollar and Rupees. Guide to invest in Innoviva stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Innoviva, along with analyst recommendations, forecasts, and comprehensive financials.

Innoviva share price movements

  • Today's Low: $18.16
    Today's High: $18.33

    Day's Volatility :0.93%

  • 52 Weeks Low: $14.33
    52 Weeks High: $21.28

    52 Weeks Volatility :32.68%

Innoviva (INVA) Returns

PeriodInnoviva, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-7.58%
0.5%
0.0%
6 Months
1.49%
-2.3%
0.0%
1 Year
15.86%
3.8%
0.0%
3 Years
17.64%
11.4%
-11.7%

Innoviva (INVA) Key Statistics

in dollars & INR

Previous Close
$18.41
Open
$18.3
Today's High
$18.33
Today's Low
$18.16
Market Capitalization
$1.2B
Today's Volume
$391.2K
52 Week High
$21.28
52 Week Low
$14.325
Revenue TTM
$352.7M
EBITDA
$221.2M
Earnings Per Share (EPS)
$0.8
PE Ratio
23.3
Profit Margin
18.31%
Quarterly Earnings Growth YOY
-0.98%
Return On Equity TTM
9.97%

How to invest in Innoviva Stock (INVA) from India?

It is very easy for Indian residents to invest directly in Innoviva from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Innoviva stock in both Indian Rupees (INR) and US Dollars (USD). Search for Innoviva or INVA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Innoviva or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Innoviva shares which would translate to 0.048 fractional shares of Innoviva as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Innoviva, in just a few clicks!

Returns in Innoviva (INVA) for Indian investors in Rupees

The Innoviva stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Innoviva investment value today

Current value as on today

₹1,20,157

Returns

₹20,157

(+20.16%)

Returns from Innoviva Stock

₹15,293 (+15.29%)

Dollar Returns

₹4,865 (+4.86%)

Indian investors sentiment towards Innoviva (INVA)

-32%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Innoviva Stock from India on INDmoney has decreased by -32% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Innoviva

  • BlackRock Inc

    15.06%

  • Sarissa Capital Management LP

    11.62%

  • Franklin Resources Inc

    10.77%

  • Vanguard Group Inc

    9.95%

  • Dimensional Fund Advisors, Inc.

    7.50%

  • Renaissance Technologies Corp

    6.92%

Analyst Recommendation on Innoviva

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Innoviva(by analysts ranked 0 to 5 stars)

Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
3
3
3
Sell
3
3
3

Analyst Forecast on Innoviva Stock (INVA)

What analysts predicted

Upside of 3.71%

Target:

$19.00

Current:

$18.32

Insights on Innoviva Stock (Ticker Symbol: INVA)

  • Price Movement

    In the last 1 month, INVA stock has moved up by 5.1%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 103.35M → 89.50M (in $), with an average decrease of 13.4% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -34.68M → 1.21M (in $), with an average increase of 2959.4% per quarter
  • INVA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.6% return, outperforming this stock by 42.8%
  • INVA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 88.8% return, outperforming this stock by 71.1%
  • Price to Sales

    ForINVA every $1 of sales, investors are willing to pay $3.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.6 for every $1 of sales.

Innoviva Technicals Summary

Sell

Neutral

Buy

Innoviva is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Innoviva (INVA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Innoviva, Inc. logo
5.93%
1.49%
15.86%
17.64%
27.94%
Biontech Se logo
-0.32%
51.19%
24.81%
-30.66%
288.02%
Regeneron Pharmaceuticals, Inc. logo
-6.9%
-37.55%
-28.89%
7.15%
74.63%
Vertex Pharmaceuticals Incorporated logo
16.87%
0.96%
13.03%
93.36%
95.94%
Alnylam Pharmaceuticals, Inc. logo
17.76%
5.53%
59.46%
84.7%
118.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Innoviva, Inc. logo
23.3
23.3
0.24
0.52
0.1
0.09
NA
10.68
Biontech Se logo
160.8
NA
0.04
-3.32
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
16.64
16.64
1.08
44.92
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.21
0.49
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Innoviva, Inc. logo
Sell
$1.2B
27.94%
23.3
18.31%
Biontech Se logo
Buy
$29.7B
288.02%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.0B
74.63%
16.64
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$118.9B
95.94%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$35.0B
118.8%
NA
-15.86%

About Innoviva

Innoviva, Inc. engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company's products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA) and umeclidinium bromide (UMEC) with a LABA, VI; GIAPREZA (angiotensin II), a vasoconstrictor to increase blood pressure in adults with septic or other distributive shock; XERAVA (eravacycline) for the treatment of complicated intra-abdominal infections in adults; and XACDURO, a beta lactamase inhibitor for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Its development pipeline includes zoliflodacin, a late-stage product candidate, a potential single oral dose cure for the treatment of uncomplicated gonorrhea. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. It has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.
Organization
Innoviva
Employees
112
CEO
Mr. Pavel Raifeld C.F.A.
Industry
Health Technology

Management People of Innoviva

NameTitle
Mr. Pavel Raifeld C.F.A.
Chief Executive Officer
Mr. Stephen Basso M.B.A.
Chief Financial Officer
Ms. Marianne Zhen CPA
Chief Accounting Officer & Secretary
Ms. Patricia M. Drake
Chief Commercial Officer-Innoviva Specialty Therapeutics, Inc.

Important FAQs about investing in INVA Stock from India :

What is Innoviva share price today?

Innoviva share price today stands at $18.32, Open: $18.30 ; Previous Close: $18.41 ; High: $18.33 ; Low: $18.16 ; 52 Week High: $21.28 ; 52 Week Low: $14.33.

The stock opens at $18.30, after a previous close of $18.41. The stock reached a daily high of $18.33 and a low of $18.16, with a 52-week high of $21.28 and a 52-week low of $14.33.

Can Indians buy Innoviva shares?

Yes, Indians can invest in the Innoviva (INVA) from India.

With INDmoney, you can buy Innoviva at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Innoviva at zero transaction cost.

How can I buy Innoviva shares from India?

It is very easy to buy Innoviva from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Innoviva (INVA) be purchased?

Yes, you can buy fractional shares of Innoviva with INDmoney app.

What are the documents required to start investing in Innoviva stocks?

To start investing in Innoviva, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Innoviva Stock (INVA)?

Today’s highest price of Innoviva (INVA) is $18.33.

Today’s lowest price of Innoviva (INVA) is $18.16.

What is today's market capitalisation of Innoviva?

Today's market capitalisation of Innoviva INVA is 1.2B

What is the 52 Week High and Low Range of Innoviva Stock (INVA)?

  • 52 Week High

    $21.28

  • 52 Week Low

    $14.33

What are the historical returns of Innoviva (INVA)?

  • 1 Month Returns

    5.93%

  • 3 Months Returns

    1.49%

  • 1 Year Returns

    15.86%

  • 5 Years Returns

    27.94%

Who is the Chief Executive Officer (CEO) of Innoviva ?

Mr. Pavel Raifeld C.F.A. is the current Chief Executive Officer (CEO) of Innoviva.